1. Rare Disease Clinical Research Network, National Institutes of Health. Updated October 2010. https://report.nih.gov/NIHfactsheets/Pdfs/RareDiseasesClinicalResearchNetwork(ORDR).pdf. Accessed on August 21, 2017.
2. US Food and Drug Administration. Orphan products: hope for people with rare disease. FDA Information for Consumers (drugs). https://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm143563.htm. Updated May 5, 2016. Accessed September 3, 2017.
3. US Food and Drug Administration. FDA orphan drug designation and approval database. https://www.accessdata.fda.gov/scripts/opdlisting/oopd/. Accessed June 5, 2017.
4. US Food and Drug Administration. Rare disease: common issues in drug development guidance for industry. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM458485.pdf. Published August 2015. Accessed June 16, 2017
5. ISEBOX Ltd/Shire. Rare disease impact report. http://www.rarediseaseimpact.com. Published April 2013. Accessed June 16, 2017.